CRT 2025

Late-Breaking Clinical Trials Coronary

Real-World Usage of Prevail Paclitaxel-Coated Balloon Compared with Other Contemporary Drug-Coated Balloons | A Two-Year Analysis from the Swedish Coronary Angiography and Angioplasty (SCAAR) Registry in Over 6,000 Patients

Speaker(s)

• 

  Sacharias von Koch, MD

  PhD student in cardiology
  Department of Cardiology, Skåne University Hospital, Lund Sweden

  Disclosure(s): No financial relationships to disclose